We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

215 hedge funds and large institutions have $3.36B invested in NPS PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $2.89B → $3.36B (+$465M)

13% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 69

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

2% more funds holding

Funds holding: 210 → 215 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

12% less call options, than puts

Call options by funds: $72.5M | Put options by funds: $82M

Holders
215
Holders Change
+5
Holders Change %
+2.38%
% of All Funds
6.18%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
49
Increased
78
Reduced
69
Closed
44
Calls
$72.5M
Puts
$82M
Net Calls
-$9.5M
Net Calls Change
-$5.8M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$65.5M
2
Norges Bank
Norges Bank
Norway
+$36.9M
3
Invesco
Invesco
Georgia
+$32.3M
4
VAM
Visium Asset Management
New York
+$29.5M
5
PC
PointState Capital
New York
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$45.8M
2
CWAM
Columbia Wanger Asset Management
Illinois
-$29.9M
3
Franklin Resources
Franklin Resources
California
-$21.8M
4
CCM
Century Capital Management
Massachusetts
-$17.2M
5
TI
Turner Investments
Pennsylvania
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
226
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$3.17M -95,900 Closed
SB
227
Suntrust Banks
Georgia
– -$2.57M -85,929 Closed
AL
228
Airain Ltd
Guernsey
– -$1.52M -50,863 Closed
Group One Trading
229
Group One Trading
Illinois
– -$952K -32,971 Closed
CCMH
230
Cornerstone Capital Management Holdings
New York
– -$952K -31,802 Closed
Capital Fund Management (CFM)
231
Capital Fund Management (CFM)
France
– -$744K -25,745 Closed
HCM
232
Highbridge Capital Management
New York
– -$720K -24,055 Closed
Renaissance Technologies
233
Renaissance Technologies
New York
– -$703K -23,500 Closed
SAM
234
Shell Asset Management
Netherlands
– -$640K -21,392 Closed
SFP
235
Santa Fe Partners
New Mexico
– -$637K -21,297 Closed
Cambridge Investment Research Advisors
236
Cambridge Investment Research Advisors
Iowa
– -$617K -20,614 Closed
SGH
237
Schonfeld Group Holdings
New York
– -$594K -19,838 Closed
SIP
238
Stoneridge Investment Partners
Pennsylvania
– -$573K -19,161 Closed
CBOA
239
Commonwealth Bank of Australia
Australia
– -$565K -18,866 Closed
QC
240
QCM Cayman
Texas
– -$541K -18,091 Closed
SG Americas Securities
241
SG Americas Securities
New York
– -$519K -17,346 Closed
Calamos Advisors
242
Calamos Advisors
Illinois
– -$447K -14,950 Closed
CEP
243
Chicago Equity Partners
Illinois
– -$341K -11,400 Closed
EMG
244
Ellington Management Group
Connecticut
– -$269K -9,000 Closed
YMRC
245
Yorktown Management & Research Company
Virginia
– -$248K -8,300 Closed
CG
246
Clinton Group
New York
– -$246K -8,235 Closed
William Blair & Company
247
William Blair & Company
Illinois
– -$239K -8,000 Closed
GMIM
248
General Motors Investment Management
New York
– -$237K -7,905 Closed
QIM
249
Quest Investment Management
Oregon
– -$223K -7,445 Closed
Truist Financial
250
Truist Financial
North Carolina
– -$214K -7,152 Closed
7 8 9
10
11

NPSP Hedge Fund Activity: Q2 2014 in Review

215 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2014, worth a combined $3.36B — up 16% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new NPSP positions and 44 closed out — a net gain of 5 holders — while 78 added to existing stakes and 69 trimmed.

The largest buyer was Wells Fargo, adding an estimated $65.5M. The largest seller was RS Investment Management, exiting entirely with an estimated $45.8M sold.

  • 215 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2014, up from 210 in Q1 2014.
  • Funds reported $3.36B of NPS PHARMACEUTICALS INC stock for Q2 2014, up 16% quarter-over-quarter.
  • 49 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2014 and 44 closed out, a net change of +5 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q2 2014 was Wells Fargo, an estimated $65.5M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q2 2014 was RS Investment Management, an estimated $45.8M sold.

Based on aggregated 13F filings for Q2 2014.